Improving the resolution and accuracy of cardiovascular phenotypes will lead to novel insights and therapies. This can occur by drilling down—understanding the genetic and cellular mechanism of a particular disease—or going broad, using computational means to analyze precision phenotypes at scale. Dr. Arnaout is currently developing computational methods to bring precision phenotyping to echocardiography. Her background as a physician-scientist informs the future scope of this work as a technology that can transform non-invasive imaging into a big-data tool for both research and clinical use. She also uses the zebrafish animal model to study cardiovascular developmental gene function and to model human cardiovascular disease.

Affiliated organizations

The AHA Precision Medicine Institute
The Chan Zuckerberg Biohub
Pediatric Cardiac Genomics Consortium
Sarnoff Cardiovascular Research Foundation
NIH National Heart, Lung and Blood Institutes